EPCAM and cancer: The interaction of this RNA aptamer with EpCAM and subsequent internalization into the colorectal cancer cells was investigated using flow cytometry and confocal microscopy and the results showed successful binding and receptor-mediated endocytosis of this DY-647 labelled aptamer, suggesting that this aptamer can be potentially applied in the advancement of targeted therapeutics and molecular imaging agents for cancer diagnosis [52].